Control of Gene Expression by the Retinoic Acid-Related Orphan Receptor Alpha in HepG2 Human Hepatoma Cells

Retinoic acid-related Orphan Receptor alpha (RORα; NR1F1) is a widely distributed nuclear receptor involved in several (patho)physiological functions including lipid metabolism, inflammation, angiogenesis, and circadian rhythm. To better understand the role of this nuclear receptor in liver, we aimed at displaying genes controlled by RORα in liver cells by generating HepG2 human hepatoma cells stably over-expressing RORα. Genes whose expression was altered in these cells versus control cells were displayed using micro-arrays followed by qRT-PCR analysis. Expression of these genes was also altered in cells in which RORα was transiently over-expressed after adenoviral infection. A number of the genes found were involved in known pathways controlled by RORα, for instance LPA, NR1D2 and ADIPOQ in lipid metabolism, ADIPOQ and PLG in inflammation, PLG in fibrinolysis and NR1D2 and NR1D1 in circadian rhythm. This study also revealed that genes such as G6PC, involved in glucose homeostasis, and AGRP, involved in the control of body weight, are also controlled by RORα. Lastly, SPARC, involved in cell growth and adhesion, and associated with liver carcinogenesis, was up-regulated by RORα. SPARC was found to be a new putative RORα target gene since it possesses, in its promoter, a functional RORE as evidenced by EMSAs and transfection experiments. Most of the other genes that we found regulated by RORα also contained putative ROREs in their regulatory regions. Chromatin immunoprecipitation (ChIP) confirmed that the ROREs present in the SPARC, PLG, G6PC, NR1D2 and AGRP genes were occupied by RORα in HepG2 cells. Therefore these genes must now be considered as direct RORα targets. Our results open new routes on the roles of RORα in glucose metabolism and carcinogenesis within cells of hepatic origin.

[1]  O. Podhajcer,et al.  Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells , 2009, International journal of cancer.

[2]  B. Staels,et al.  Inhibition of adipocyte differentiation by RORα , 2009, FEBS letters.

[3]  V. Laudet,et al.  Rev-erbalpha2 mRNA encodes a stable protein with a potential role in circadian clock regulation. , 2009, Molecular endocrinology.

[4]  G. Semenza,et al.  Regulation of oxygen homeostasis by hypoxia-inducible factor 1. , 2009, Physiology.

[5]  T. Murohara,et al.  Adiponectin and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[6]  A. Jetten.  Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism , 2009, Nuclear receptor signaling.

[7]  M. Tang,et al.  SPARC in cancer biology: its role in cancer progression and potential for therapy. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[8]  P. Saha,et al.  Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease , 2008, Science.

[9]  In-kyu Lee,et al.  Transcriptional Activation of HIF-1 by RORα and its Role in Hypoxia Signaling , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[10]  O. Podhajcer,et al.  Adenovirus‐mediated inhibition of SPARC attenuates liver fibrosis in rats , 2008, The journal of gene medicine.

[11]  J. Chou,et al.  Mutations in the glucose‐6‐phosphatase‐α (G6PC) gene that cause type Ia glycogen storage disease , 2008, Human mutation.

[12]  B. Staels,et al.  The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism , 2008, Diabetes & vascular disease research.

[13]  S. Serratì,et al.  The plasminogen activation system in inflammation. , 2008, Frontiers in bioscience : a journal and virtual library.

[14]  Liming Pei,et al.  Nuclear receptors: Decoding metabolic disease , 2008, FEBS letters.

[15]  R. A. Reid,et al.  Rev-erbα, a Heme Sensor That Coordinates Metabolic and Circadian Pathways , 2007, Science.

[16]  J. Gimble,et al.  Gene expression profiling reveals a regulatory role for RORα and RORγ in phase I and phase II metabolism , 2007 .

[17]  G. Lippi,et al.  Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. , 2007, Cancer treatment reviews.

[18]  D. Gold,et al.  RORα in genetic control of cerebellum development: 50 staggering years , 2007, Brain Research.

[19]  S. Fan,et al.  SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma , 2006, The Journal of pathology.

[20]  Vincent Laudet,et al.  Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.

[21]  M. Lazar,et al.  The Orphan Nuclear Receptor Rev-erbα Regulates Circadian Expression of Plasminogen Activator Inhibitor Type 1* , 2006, Journal of Biological Chemistry.

[22]  F. Rastinejad.  Faculty Opinions recommendation of Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A. , 2006 .

[23]  C. Fontaine,et al.  The Gene Encoding Fibrinogen-β Is a Target for Retinoic Acid Receptor-Related Orphan Receptor α , 2005 .

[24]  P. Strömstedt,et al.  Identification of the human ApoAV gene as a novel RORα target gene , 2005 .

[25]  J. Pouysségur,et al.  The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1. , 2004, The Biochemical journal.

[26]  B. Fournier,et al.  Crystal Structure of the Human RORα Ligand Binding Domain in Complex with Cholesterol Sulfate at 2.2 Å* , 2004, Journal of Biological Chemistry.

[27]  Xiaodong Yang,et al.  HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells. , 2003, Journal of hepatology.

[28]  Pedro Iglesias,et al.  The role of the novel adipocyte-derived hormone adiponectin in human disease. , 2003, European journal of endocrinology.

[29]  V. Laudet,et al.  The nuclear receptor superfamily , 2003, Journal of Cell Science.

[30]  D. Monté,et al.  Transcriptional Regulation of Human Rev-erbα Gene Expression by the Orphan Nuclear Receptor Retinoic Acid-related Orphan Receptor α* , 2002, The Journal of Biological Chemistry.

[31]  E. Raspé,et al.  Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription. , 2002, Journal of lipid research.

[32]  C. Suen,et al.  Identification of Reverbα as a Novel RORα Target Gene* , 2002, The Journal of Biological Chemistry.

[33]  I. Gérin,et al.  The glucose-6-phosphatase system. , 2002, The Biochemical journal.

[34]  H. Gascan,et al.  Functional Interaction of STAT3 Transcription Factor with the Coactivator NcoA/SRC1a* , 2002, The Journal of Biological Chemistry.

[35]  J. Mariani,et al.  Increased Ischemia-Induced Angiogenesis in the Staggerer Mouse, a Mutant of the Nuclear Receptor Ror&agr; , 2001, Circulation Research.

[36]  J. Mariani,et al.  Transcriptional Regulation of Apolipoprotein C-III Gene Expression by the Orphan Nuclear Receptor RORα* , 2001, The Journal of Biological Chemistry.

[37]  J. Mariani,et al.  The orphan nuclear receptor RORα is a negative regulator of the inflammatory response , 2001 .

[38]  H. Stunnenberg,et al.  Differential binding and transcriptional behaviour of two highly related orphan receptors, ROR alpha(4) and ROR beta(1). , 2000, Biochimica et biophysica acta.

[39]  H. Green,et al.  Targeted Ablation of the Murine Involucrin Gene , 2000, The Journal of cell biology.

[40]  V. Giguère,et al.  Modulation of the Far-Upstream Enhancer of the Rat α-Fetoprotein Gene by Members of the RORα, Rev-erbα, and Rev-erbβ Groups of Monomeric Orphan Nuclear Receptors , 2000 .

[41]  L. Madsen,et al.  Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. , 1999, Journal of lipid research.

[42]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.

[43]  G. Luc,et al.  Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. , 1998, Circulation.

[44]  J. Auwerx,et al.  Transcriptional Regulation of Apolipoprotein A-I Gene Expression by the Nuclear Receptor RORα* , 1997, The Journal of Biological Chemistry.

[45]  M. Mehtali,et al.  Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli , 1996, Journal of virology.

[46]  T. Krieg,et al.  A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription. , 1995, Matrix biology : journal of the International Society for Matrix Biology.

[47]  R. Weinberg,et al.  E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Eghbali,et al.  Expression of SPARC in normal and fibrotic livers , 1995, Hepatology.

[49]  C. Carlberg,et al.  Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. , 1995, Nucleic acids research.

[50]  R. Evans,et al.  Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. , 1994, Genes & development.

[51]  M. Becker‐André,et al.  Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. , 1993, Biochemical and biophysical research communications.

[52]  N. Delhaye-bouchaud,et al.  Evidence for a Hyperexcitability State of Staggerer Mutant Mice Macrophages , 1992, Journal of neurochemistry.

[53]  H. Kwaan,et al.  The role of plasminogen-plasmin system in cancer. , 2009, Cancer treatment and research.

[54]  R. A. Reid,et al.  Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. , 2007, Science.

[55]  B. Hamilton,et al.  ROR alpha in genetic control of cerebellum development: 50 staggering years. , 2007, Brain research.

[56]  J. Gimble,et al.  Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. , 2007, Physiological genomics.

[57]  C. Fontaine,et al.  The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha. , 2005, Molecular endocrinology.

[58]  P. Strömstedt,et al.  Identification of the human ApoAV gene as a novel RORalpha target gene. , 2005, Biochemical and biophysical research communications.

[59]  D. Monté,et al.  Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alpha. , 2002, The Journal of biological chemistry.

[60]  C. Suen,et al.  Identification of Reverb(alpha) as a novel ROR(alpha) target gene. , 2002, The Journal of biological chemistry.

[61]  J. Mariani,et al.  The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. , 2001, EMBO reports.

[62]  V. Giguère,et al.  Modulation of the far-upstream enhancer of the rat alpha-fetoprotein gene by members of the ROR alpha, Rev-erb alpha, and Rev-erb beta groups of monomeric orphan nuclear receptors. , 2000, DNA and Cell Biology.